<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04420208</url>
  </required_header>
  <id_info>
    <org_study_id>202004014RINB</org_study_id>
    <nct_id>NCT04420208</nct_id>
  </id_info>
  <brief_title>Ameliorating the Obstacle of Pap Smear</brief_title>
  <official_title>Ameliorating the Obstacle of Pap Smear: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To reduce the procedural pain of Pap smear, this study expects to apply the peak-end rule to
      Pap smear by prolonging the insertion of speculum after samples are obtained from the cervix.
      This study aims to conduct a randomized controlled study at National Taiwan University
      Hospital (NTUH). The investigators expect to compare the recalled pain intensity of the
      intervention and control groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: In order to reduce the procedural pain, this study expects to apply the peak-end
      rule to Pap smear by prolonging the insertion of speculum after samples are obtained from the
      cervix. Methods: This study aims to conduct a randomized controlled study at National Taiwan
      University Hospital (NTUH). Approximately 200 subjects will be recruited. The investigators
      will utilize the peak-end rule by adding a non-painful event after the most uncomfortable
      phase in the intervention group. All study subjects are requested to score on a numeric pain
      scale every 20 seconds during and right after the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects are divided into two groups, one with traditional Pap smear and one with Pap smear adding a non-painful procedure at the end. The investigators will compare the real-time pain score and recalled pain to check whether the theory works.</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants will not know their grouping and operator will not know the grouping until the last second.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Recalled pain score</measure>
    <time_frame>12 weeks</time_frame>
    <description>The primary outcome measure will be the recalled pain intensity during the smear examination. Pain will also be assessed by using a 0-10 numerical pain scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjects' willing to receive further Pap tests</measure>
    <time_frame>12 weeks</time_frame>
    <description>The investigators will contact the subjects on phone 3 months after the examination to ask whether they are willing to undergo another Pap smear in the next year and in the next 3 years or not. A questionnaire will be used to grade the willingness.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adding a non-painful event after the most uncomfortable phase of Pap smear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard Pap-smear procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pap smear</intervention_name>
    <description>Adding a non-painful event after the most uncomfortable phase of Pap smear</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biological female

          -  Aged 30-70

          -  Provision of written informed consent

        Exclusion Criteria:

          -  History of pelvic or vaginal surgery, active infectious gynecologic complaint, prior
             intervention for abnormal cervical cytology

          -  Incapable of understanding the numeric pain scale

          -  Incapable of communicating in Chinese, English or Taiwanese

          -  Prior cervical cancer diagnosis

          -  Prior hysterectomy

          -  Pregnant women

          -  Those who use painkillers within 24 hours of this project
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chien-Hsieh Chiang, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Attending physician</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chien-Hsieh Chiang, MD, MPH</last_name>
    <phone>+886-2-23123456</phone>
    <phone_ext>66699</phone_ext>
    <email>jiansie@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hung-Kuan Yen, MS</last_name>
    <phone>+886-919-207-962</phone>
    <email>b04401122@ntu.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hosputal</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chien-Hsieh Chiang, MD, MPH</last_name>
      <phone>+886-2-23123456</phone>
      <phone_ext>66699</phone_ext>
      <email>jiansie@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 4, 2020</study_first_submitted>
  <study_first_submitted_qc>June 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 7, 2020</last_update_submitted>
  <last_update_submitted_qc>June 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cervical cancer</keyword>
  <keyword>Pap smear</keyword>
  <keyword>pain control</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

